Full Breakdown
Congolese Virologist Jean-Jacques Muyembe-Tamfum and Belgian Microbiologist Peter Piot Receive 2026 Virchow Prize
By Drooid · · How we work
Award Ceremony Highlights
On Saturday, October 10, the Virchow Prize 2026 was presented to Jean-Jacques Muyembe-Tamfum and Peter Piot at Berlin’s city hall (Rotes Rathaus). The award, endowed with 500,000 euros, is split equally between the two laureates. The ceremony was broadcast by Berlin’s public television network rbb and reported by the Congolese News Agency. The prize decision had been announced earlier on June 2 by the Virchow Foundation.
Five Decades of Ebola Research and Epidemic Preparedness
Muyembe’s involvement began in 1976 during the first identified Ebola outbreak in what is now the Democratic Republic of the Congo (DRC). He conducted field investigations in Yambuku, collected patient samples, and later helped build national capacities for surveillance, diagnosis, and outbreak response as Director General of the National Institute of Biomedical Research in Kinshasa. His work contributed to the development of the monoclonal antibody mAb114, which was evaluated in the PALM clinical trial that started in November 2018; results published in 2019 showed lower mortality for patients receiving mAb114 or REGN-EB3 compared with the ZMapp comparator.
Peter Piot participated in the laboratory analysis of the 1976 samples in Antwerp, aiding the identification of the Ebola virus. He later directed the first executive office of UNAIDS from 1995 to 2008 and has spent his career strengthening international coordination of infectious-disease control, linking research institutions, public agencies, and multilateral organizations.
Foundation’s Rationale and Historical Context
The Virchow Foundation, created in 2021 to commemorate the bicentennial of German physician Rudolf Virchow, awards the prize annually for outstanding contributions to global health. In its June 2 announcement, the foundation highlighted the duo’s combined legacy of “patient investigation and laboratory work” and emphasized their roles in advancing both pathogen discovery and therapeutic evaluation.
Impact on Global Health Cooperation
The laureates’ careers illustrate a continuous pathway from early field work to the establishment of national research systems and international crisis-preparedness mechanisms. Their contributions have reinforced the DRC’s capacity to detect and respond rapidly to infectious-disease threats and have informed broader global strategies for epidemic control, including the development and deployment of effective Ebola treatments.
Data & Statistics
- Prize endowment: 500,000 euros, shared equally.
- PALM trial (Nov 2018–2019): mortality reduction for patients treated with mAb114 or REGN-EB3 versus ZMapp.
- Piot’s tenure as UNAIDS Executive Director: 1995-2008.
- Muyembe’s leadership at the National Institute of Biomedical Research: ongoing since the 1990s, overseeing multiple Ebola outbreak responses.